Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
29 Agosto 2024 - 3:17PM
Vericel Corporation (NASDAQ:VCEL), a leader in advanced
therapies for the sports medicine and severe burn care markets,
today announced that Nick Colangelo, President and CEO, and Joe
Mara, CFO, will participate in a fireside chat at the Morgan
Stanley 22nd Annual Global Healthcare Conference at 1:05 p.m. ET on
Friday, September 6, 2024.
A webcast of the presentation will be available on the Investor
Relations section of the Vericel Corporation website at:
http://investors.vcel.com.
About Vericel Corporation
Vericel is a leading provider of advanced therapies for the
sports medicine and severe burn care markets. The Company combines
innovations in biology with medical technologies, resulting in a
highly differentiated portfolio of innovative cell therapies and
specialty biologics that repair injuries and restore lives. Vericel
markets three products in the United States. MACI® (autologous
cultured chondrocytes on porcine collagen membrane) is an
autologous cellularized scaffold product indicated for the repair
of symptomatic, single or multiple full-thickness cartilage defects
of the knee with or without bone involvement in adults.
Epicel® (cultured epidermal autografts) is a permanent skin
replacement for the treatment of patients with deep dermal or full
thickness burns greater than or equal to 30% of total body surface
area. Vericel also holds an exclusive license for North American
rights to NexoBrid® (anacaulase-bcdb), a biological orphan
product containing proteolytic enzymes, which is indicated for
eschar removal in adults and pediatric patients with deep
partial-thickness and/or full-thickness burns. For more
information, please visit www.vcel.com.
Epicel and MACI are registered trademarks of Vericel
Corporation. NexoBrid is a registered trademark of MediWound Ltd.
and is used under license to Vericel Corporation. © 2024 Vericel
Corporation. All rights reserved.
Investor Contact:
Eric Burns
ir@vcel.com
+1 (734) 418-4411
Media Contact: Julie
Downsmedia@vcel.com
Grafico Azioni Vericel (NASDAQ:VCEL)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Vericel (NASDAQ:VCEL)
Storico
Da Set 2023 a Set 2024